Laura Lin
-
- Quality and Safety in Healthcare 5
- Emergency Medical Services top 5%
- Patient Safety and Medication Errors 4
- Molecular Biology top 10%
- Glycosylation and Glycoproteins Research 6
- Viral Infectious Diseases and Gene Expression in Insects 6
- Protein purification and stability 5
-
- Monoclonal and Polyclonal Antibodies Research 16
-
- Healthcare Technology and Patient Monitoring 5
-
- Peptidase Inhibition and Analysis 4
Laura Lin
53 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 158
- Medical Laboratory Technology 74
- Emergency Medical Services 121
- Molecular Biology 818
- Health Information Management 51
- Research and Theory 10
Countries citing papers authored by Laura Lin
This map shows the geographic impact of Laura Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Lin more than expected).
Fields of papers citing papers by Laura Lin
This network shows the impact of papers produced by Laura Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Lin. The network helps show where Laura Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 18 | |
| 6 | 2021 | 17 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 115 | |
| 9 | 2020 | 4 | |
| 10 | 2020 | 37 | |
| 11 | 2017 | 10 | |
| 12 | 2012 | 15 | |
| 13 | Determinants of Perceived Usefulness and Perceived Ease of Use in Individual Adoption of Social Network Sites | 2010 | 15 |
| 14 | 2010 | 4 | |
| 15 | 2005 | 0 | |
| 16 | Patient safety, potential adverse drug events, and medical device design: a human factors engineering approach | 2001 | 0 |
| 17 | 2001 | 100 | |
| 18 | 2001 | 44 | |
| 19 | Shift of Fiduciary Duty Upon Corporate Insolvency: Proper Scope of Directors' Duty to Creditors | 1993 | 8 |
| 20 | 1993 | 25 |
About Laura Lin
Laura Lin is a scholar working on Medical Laboratory Technology, Research and Theory, Radiology, Nuclear Medicine and Imaging, Emergency Medical Services and Molecular Biology, having authored 57 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), Quality and Safety in Healthcare (5 papers), Protein purification and stability (5 papers), Healthcare Technology and Patient Monitoring (5 papers), Patient Safety and Medication Errors (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Medical Laboratory Technology (74 citations), Emergency Medical Services (121 citations), Molecular Biology (818 citations), Health Information Management (51 citations) and Research and Theory (10 citations). Laura Lin has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Kim J. Vicente, Mark Stahl, D. John Doyle, Bryan A. Liang, Kristina I. Boström, Lidia Mosyak, Yucheng Yao, Ron Kriz, Robert Czerwiński and Lori Fitz. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, Scientific Reports, Antibodies and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.